[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370335-105":59,"doc-detail-370335-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-a-conserved-subset-of-cold-tumors-responsive-to-immune-checkpoint-blockade","Identification of a conserved subset of cold tumors responsive to immune checkpoint blockade","","Immune checkpoint blockade (ICB) efficacy relies on restoring immune recognition, yet cold tumors with poor immune infiltration often resist treatment. This study examines how loss of transforming growth factor-beta (TGFβ) signaling, tied to DNA misrepair, shapes immune context and predicts ICB response. Transcriptomic analyses define a high βAlt score and test an ICB-resistant preclinical model using TGFβ inhibition, radiation, and/or ICB. TGFβ inhibition with radiotherapy increases NK-cell activation and lymphocyte recruitment, converting cold tumors into ICB-responsive tumors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-a-conserved-subset-of-cold-tumors-responsive-to-immune-checkpoint-blockade/370335/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-a-conserved-subset-of-cold-tumors-responsive-to-immune-checkpoint-blockade/370335.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the βAlt score represent in this study?","Question",{"text":112,"@type":113},"The βAlt score represents low expression of a TGFβ-target signature together with high expression of genes involved in error-prone DNA repair.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is ICB response predicted using βAlt?",{"text":117,"@type":113},"A high βAlt score predicts ICB response in clinical trial transcriptomic data and is also associated with an immune-poor (cold) tumor microenvironment in both human and mouse tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapy combination converts cold tumors into ICB-responsive tumors?",{"text":121,"@type":113},"Preclinical modeling shows that TGFβ inhibition followed by radiotherapy can convert an immune-poor, high βAlt tumor into an immune-rich, ICB-responsive tumor.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370335,1790305676,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Open access Original research  \n Identification of a conserved subset of cold  \ntumors responsive to immune checkpoint blockade  \nJade Moore,1 Jim Gkantalis,1 Ines Guix,1 William Chou,1 Kobe Yuen,2 Ann A Lazar,3 Matthew Spitzer,4 Alexis Combes,5 Mary Helen Barcellos-Hoff  1  \nTo cite: Moore J, Gkantalis J, Guix I, et al. Identification of a conserved subset of cold tumors responsive to immune checkpoint  \nblockade. Journal for ImmunoTherapy of Cancer 2025;13:e010528 . doi:10 . 1136/ jitc-2024-010528  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2024-010528](jitc-2024-010528)) .  \nAccepted 03 February 2025  \n© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Mary Helen Barcellos-Hoff; MaryHelen. Barcellos-Hoff@ [ucsf.edu](ucsf.edu)  \nABSTRACT  \nBackground The efficacy of immune checkpoint blockade (ICB) depends on restoring immune recognition of cancer cells that have evaded immune surveillance. Transforming growth factor-beta (TGFβ) is associated with immune-poor, so-called cold tumors whereas loss of its signaling promotes DNA misrepair that could stimulate immune response.  \nMethods We analyzed transcriptomic data from IMvigor210, The Cancer Genome Atlas, and Tumor Immune Syngeneic MOuse data sets to evaluate the predictive value of high βAlt, a score representing low expression of a signature consisting of TGF β targets and high expression of genes involved in error-prone DNA repair. The immune context of βAlt was assessed by evaluating tumor-educated immune signatures. An ICB-resistant, high βAlt preclinical tumor model was treated with a TGF β inhibitor, radiation, and/or ICB and assessed for immune composition and tumor control.  \nResults We found that a high βAlt score predicts ICB response yet is paradoxically associated with an immune-poor tumor microenvironmentcancer in both human and mouse tumors. We postulated that high βAlt cancers consist of cancer cells in which loss of TGF β signaling generates a TGF β  \nrich, immunosuppressive tumor microenvironment. Accordingly, preclinical modeling showed that TGF β inhibition followed by radiotherapy could convert an immune-poor, high βAlt tumor to an immune-rich, ICB-responsive tumor. Mechanistically, TGF β inhibition increased activated natural killer (NK) cells, which were required to recruit lymphocytes to respond to ICBin irradiated tumors. NK cell activation signatures were also increased in high βAlt, cold mouse and human tumors that responded to ICB.  \nConclusions These studies indicate that loss of TGF β signaling competency and gain of error-prone DNA repair identifies a subset of cold tumors that are responsive to ICB. Our mechanistic studies show that inhibiting TGF β activity can convert a high βAlt, cold tumor into ICB-responsive tumors via NK cells. A biomarker consisting of combined TGF β , DNA repair, and immune context signatures is a means to prospectively identify patients whose cancers may be converted from cold to hot with appropriate therapy.  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ For some patients with cancers infiltrated with lymphocytes, response to immune checkpoint blockade (ICB) provides durable tumor control. However, an ICB response for patients whose tumors lack lymphocytic infiltration is considered unlikely.\u003Cbr>WHAT THIS STUDY ADDS |\n| ⇒ The βAlt score, which reports a DNA repair deficiency caused by loss of transforming growth factor-beta (TGFβ) signaling, predicts response to ICB in clinical trial data from IMvigor210 patients with metastatic bladder cancer and for patients with melanoma. Notably, transcriptomic assessment of the immune context shows that these are immune-poor, socalled cold tumors. Preclinical m","cbCaih5PcXZ5GHN6","https://ap.wps.com/l/cbCaih5PcXZ5GHN6","pdf",7882062,14,"English","# Abstract\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy\n# Background","[{\"question\":\"What does the βAlt score represent in this study?\",\"answer\":\"The βAlt score represents low expression of a TGFβ-target signature together with high expression of genes involved in error-prone DNA repair.\"},{\"question\":\"How is ICB response predicted using βAlt?\",\"answer\":\"A high βAlt score predicts ICB response in clinical trial transcriptomic data and is also associated with an immune-poor (cold) tumor microenvironment in both human and mouse tumors.\"},{\"question\":\"What therapy combination converts cold tumors into ICB-responsive tumors?\",\"answer\":\"Preclinical modeling shows that TGFβ inhibition followed by radiotherapy can convert an immune-poor, high βAlt tumor into an immune-rich, ICB-responsive tumor.\"}]","Identification of a conserved subset of cold tumors responsive to immune checkpoint blockade | PDF",1790188087,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffcf2fae4e97741fea69af17ef5190fb.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57feae1623c3bdeda8aaeb5cfef787d6.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0b3f2d721b38bdb80f5a563c8066d7d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b14674e4e2bb8b884ce5f22c6987a20c.webp",980,1306]